Semaglutide — the key ingredient in Ozempic and Wegovy — had been in shortage since 2022. Now that supply has stabilized, state-licensed compounding pharmacies and physicians must stop selling ...
Hosted on MSN18m
Should You Buy VKTX Stock Amid Renewed M&A Speculations?Shares of Viking Therapeutics VKTX rose nearly 8% on Friday after several third-party reports suggested that it was being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback